DrugRepV Browse Page


DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for CPE reduction assay are 143




DrugRepV_ID Antiviral Name
Drug type
Primary Indication
Secondary Indication
Strain
Pathways
Assay
Activity
Clinical Status
 References
DrugRepV_3530Carbinoxamine maleate
Respiratory System
Allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis
Influenza virus
A/Puerto Rico/8/1934(H1N1)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3531Carbinoxamine maleate
Respiratory System
Allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis
Influenza virus
A/Guizhou/54/1989(H3N2)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3532Carbinoxamine maleate
Respiratory System
Allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis
Influenza virus
A/Shanghai/37T/2009(H1N1)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3533Carbinoxamine maleate
Respiratory System
Allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis
Influenza virus
B/Shanghai/2017(BY)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3534Carbinoxamine maleate
Respiratory System
Allergic rhinitis, vasomotor rhinitis and allergic conjunctivitis
Influenza virus
A/H7N9/4664T/2013 (H7N9)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3535Chlorpheniramine Maleate
Respiratory System
Allergic reactions | Hay fever | Rhinitis | Urticaria | Asthma
Influenza virus
A/Puerto Rico/8/1934(H1N1)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3536Chlorpheniramine Maleate
Respiratory System
Allergic reactions | Hay fever | Rhinitis | Urticaria | Asthma
Influenza virus
A/Guizhou/54/1989(H3N2)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3537Chlorpheniramine Maleate
Respiratory System
Allergic reactions | Hay fever | Rhinitis | Urticaria | Asthma
Influenza virus
A/Shanghai/37T/2009(H1N1)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3538Chlorpheniramine Maleate
Respiratory System
Allergic reactions | Hay fever | Rhinitis | Urticaria | Asthma
Influenza virus
B/Shanghai/2017(BY)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_3539Chlorpheniramine Maleate
Respiratory System
Allergic reactions | Hay fever | Rhinitis | Urticaria | Asthma
Influenza virus
A/H7N9/4664T/2013 (H7N9)
Pathway
CPE reduction assay
Decrease (50 %)
Approved
30459739
DrugRepV_41032-(4-tert-butylphenyl)-N-[(E)-(3,4-diethoxyphenyl)methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41042-(4-tert-butylphenyl)-N-[(E)-(3,5-dibromo-4-methoxyphenyl)methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41052-(4-tert-butylphenyl)-N-[(E)-[4-(diethylamino)-2-hydroxyphenyl]methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41062-(4-tert-butylphenyl)-N-[(E)-[4-(trifluoromethyl)phenyl]methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41072-(4-tert-butylphenyl)-N-[(E)-[4-(methylsulfanyl)phenyl]methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41082-(4-tert-butylphenyl)-N-[(E)-(4-methylphenyl)methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41092-(4-tert-butylphenyl)-N-[(1E)-2-[(1-methylnaphthalen-2-yl)oxy]ethylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41102-(4-tert-butylphenyl)-N-[(E)-[4-(propan-2-yl)phenyl]methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41112-(4-tert-butylphenyl)-N-[(1E)-1-phenylpropylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_4112N-[(E)-(4-bromophenyl)methylidene]-2-phenylcyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_4113N-[(E)-(4-hydroxyphenyl)methylidene]-2-phenylcyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_4114N-[(E)-(4-cyclohexylphenyl)methylidene]-2-phenylcyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_4115N-[(1E)-1-(4-methoxyphenyl)ethylidene]-2-phenylcyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_4116(2E)-3-(4-tert-butylphenyl)-N-[(E)-(3,4-diethoxyphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
NA
NA
CPE reduction assay
Decrease (50 %)
NA
23380636
DrugRepV_41492-(4-tert-butylphenyl)-N-[(E)-(4-ethoxyphenyl)methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_41502-(4-tert-butylphenyl)-N-[(E)-[4-(trifluoromethyl)phenyl]methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4151N-[(E)-(4-hydroxyphenyl)methylidene]-2-phenylcyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4152N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]-2-phenylcyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4153N-[(1E)-1-(4-methoxyphenyl)ethylidene]-2-phenylcyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4154(2E)-3-(4-tert-butylphenyl)-N-[(E)-(3,4-diethoxyphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_41552-(4-tert-butylphenyl)-N-[(E)-(4-ethoxyphenyl)methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_41562-(4-tert-butylphenyl)-N-[(E)-(4-hydroxyphenyl)methylidene]cyclopropane-1-carbohydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4157(2E)-3-(4-tert-butylphenyl)-N-[(E)-(4-ethoxyphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4158(2E)-3-(4-tert-butylphenyl)-N-[(E)-(4-methylphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4159(2E)-3-(4-methylphenyl)-N-[(E)-(4-methylphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4160(2E)-N-[(E)-(4-methylphenyl)methylidene]-3-phenylprop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4161(2E)-3-(4-tert-butylphenyl)-N-[(E)-[4-(propan-2-yl)phenyl]methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4162(2E)-3-(4-tert-butylphenyl)-N-[(E)-(4-tert-butylphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4163(2E)-3-(4-tert-butylphenyl)-N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4164(2E)-N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]-3-phenylprop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4165(2E)-3-(4-tert-butylphenyl)-N-[(E)-phenylmethylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4166(2E)-3-(4-tert-butylphenyl)-N-[(E)-(4-nitrophenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4167(2E)-3-(4-tert-butylphenyl)-N-[(1E)-1-(4-chlorophenyl)ethylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4168(2E)-3-(4-tert-butylphenyl)-N-[(1E)-1-(pyrazin-2-yl)ethylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4169(2E)-3-(4-tert-butylphenyl)-N-[(1E)-1-(4-ethoxyphenyl)ethylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4170(2E)-N-[(1E)-1-{[1,1-biphenyl]-4-yl}ethylidene]-3-(4-tert-butylphenyl)prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4171(2E)-N-[(E)-(4-ethoxyphenyl)methylidene]-3-(4-methylphenyl)prop-2-enehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4172(2E)-3-(4-tert-butylphenyl)-N-{[4-(trifluoromethyl)phenyl]methyl}prop-2-enamide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4173(2E)-3-phenyl-N-{[4-(trifluoromethyl)phenyl]methyl}prop-2-enamide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4174(2E)-N-({[1,1-biphenyl]-4-yl}methyl)-3-(4-tert-butylphenyl)prop-2-enamide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4175(2E)-N-({[1,1-biphenyl]-4-yl}methyl)-3-phenylprop-2-enamide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_41763-(4-tert-butylphenyl)-N-[(E)-(4-ethoxyphenyl)methylidene]propanehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4177N-[(E)-(4-ethoxyphenyl)methylidene]-3-phenylpropanehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_41783-(4-tert-butylphenyl)-N-[(E)-(4-methylphenyl)methylidene]propanehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4179N-[(E)-(4-methylphenyl)methylidene]-3-phenylpropanehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_41803-(4-tert-butylphenyl)-N-[(E)-(4-hydroxyphenyl)methylidene]propanehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4181N-[(E)-(4-methylphenyl)methylidene]-3-phenylpropanehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_41823-(4-tert-butylphenyl)-N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]propanehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4183N-[(E)-(4-cyclohexylphenyl)methylidene]-3-phenylpropanehydrazide
NA
NA
Chikungunya virus
889
NA
CPE reduction assay
Decrease (50 %)
NA
29336951
DrugRepV_4224(2E)-3-(4-tert-butylphenyl)-N-[(E)-(4-ethoxyphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42253-[(E)-{[2-(4-methylphenyl)-1H-indol-3-yl]methylidene}amino]-1-(2-phenylethyl)thiourea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4226(2E)-N-[(E)-(4-ethoxyphenyl)methylidene]-3-[4-(propan-2-yl)phenyl]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4227(2E)-N-[(E)-(4-ethoxyphenyl)methylidene]-3-[4-(trifluoromethyl)phenyl]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4228(2E)-N-[(E)-(4-ethoxyphenyl)methylidene]-3-(4-methoxyphenyl)prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4229(2E)-3-{[1,1-biphenyl]-4-yl}-N-[(E)-(4-ethoxyphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4230(2E)-N-[(E)-(4-methylphenyl)methylidene]-3-[4-(propan-2-yl)phenyl]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4231(2E)-N-[(E)-(4-methylphenyl)methylidene]-3-[4-(trifluoromethyl)phenyl]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4232(2E)-3-(4-methoxyphenyl)-N-[(E)-(4-methylphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4233(2E)-3-{[1,1-biphenyl]-4-yl}-N-[(E)-(4-methylphenyl)methylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4234(2E)-N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]-3-[4-(propan-2-yl)phenyl]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4235(2E)-N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]-3-[4-(trifluoromethyl)phenyl]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4236(2E)-N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]-3-(4-methoxyphenyl)prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4237(2E)-3-{[1,1-biphenyl]-4-yl}-N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4238(2E)-N-[(E)-(4-hydroxyphenyl)methylidene]-3-[4-(propan-2-yl)phenyl]prop-2-enehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4239N-[(E)-(4-ethoxyphenyl)methylidene]naphthalene-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4240N-[(E)-(4-ethoxyphenyl)methylidene]quinoline-3-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4241N-[(E)-(4-ethoxyphenyl)methylidene]quinoline-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4242N-[(E)-(4-ethoxyphenyl)methylidene]-1H-indole-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4243N-[(E)-(4-ethoxyphenyl)methylidene]-1H-1,3-benzodiazole-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4244N-[(E)-(4-methylphenyl)methylidene]naphthalene-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4245N-[(E)-(4-methylphenyl)methylidene]quinoline-3-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4246N-[(E)-(4-methylphenyl)methylidene]quinoline-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4247N-[(E)-(4-methylphenyl)methylidene]-1H-indole-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4248N-[(E)-(4-methylphenyl)methylidene]-1H-1,3-benzodiazole-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4249N-[(E)-(4-hydroxyphenyl)methylidene]naphthalene-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4250N-[(E)-(4-hydroxyphenyl)methylidene]quinoline-3-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4251N-[(E)-(4-hydroxyphenyl)methylidene]quinoline-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4252N-[(E)-(4-hydroxyphenyl)methylidene]-1H-indole-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4253N-[(E)-(4-hydroxyphenyl)methylidene]-1H-1,3-benzodiazole-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4254N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]naphthalene-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4255N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]quinoline-3-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4256N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]quinoline-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4257N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]-1H-indole-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4258N-[(1E)-1-(4-cyclohexylphenyl)ethylidene]-1H-1,3-benzodiazole-2-carbohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42593-(4-tert-butylphenyl)-N-[(E)-(4-ethoxyphenyl)methylidene]-3-oxopropanehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42603-(4-tert-butylphenyl)-N-[(E)-(4-methylphenyl)methylidene]-3-oxopropanehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42613-(4-tert-butylphenyl)-N-[(E)-(4-hydroxyphenyl)methylidene]-3-oxopropanehydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42623-[(1E)-2-(4-tert-butylphenyl)ethenyl]-1-[(E)-[(4-ethoxyphenyl)methylidene]amino]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42633-[(1E)-2-(4-tert-butylphenyl)ethenyl]-1-[(E)-[(4-methylphenyl)methylidene]amino]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42643-[(1E)-2-(4-tert-butylphenyl)ethenyl]-1-[(E)-[(4-hydroxyphenyl)methylidene]amino]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42653-[(1E)-2-(4-tert-butylphenyl)ethenyl]-1-[(E)-[1-(4-cyclohexylphenyl)ethylidene]amino]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42661-[(E)-[(4-ethoxyphenyl)methylidene]amino]-3-(2-phenylethyl)thiourea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42671-[(E)-[(4-methylphenyl)methylidene]amino]-3-(2-phenylethyl)thiourea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42681-[(E)-[(4-hydroxyphenyl)methylidene]amino]-3-(2-phenylethyl)thiourea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42691-[(E)-[1-(4-cyclohexylphenyl)ethylidene]amino]-3-(2-phenylethyl)thiourea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42703-[(1E)-2-(4-tert-butylphenyl)ethenyl]-1-[(4-ethoxyphenyl)methyl]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42713-[(1E)-2-(4-tert-butylphenyl)ethenyl]-1-[(4-methylphenyl)methyl]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42721-benzyl-3-[(1E)-2-(4-tert-butylphenyl)ethenyl]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42731-[(4-methoxyphenyl)methyl]-3-[(1E)-2-phenylethenyl]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42741-[(4-methylphenyl)methyl]-3-[(1E)-2-phenylethenyl]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42753-[(1E)-2-(4-tert-butylphenyl)ethenyl]-1-(4-methylphenyl)urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42763-[(1E)-2-(4-tert-butylphenyl)ethenyl]-1-(4-hydroxyphenyl)urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42771-(4-methylphenyl)-3-[(1E)-2-phenylethenyl]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42781-(4-hydroxyphenyl)-3-[(1E)-2-phenylethenyl]urea
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4279N-[(2E)-3-(4-tert-butylphenyl)prop-2-enoyl]-4-ethoxybenzohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4280N-[(2E)-3-(4-tert-butylphenyl)prop-2-enoyl]-4-methylbenzohydrazide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42812-[(1E)-2-(4-tert-butylphenyl)ethenyl]-5-(4-ethoxyphenyl)-1,3,4-oxadiazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42822-[(1E)-2-(4-tert-butylphenyl)ethenyl]-5-(4-methylphenyl)-1,3,4-oxadiazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42832-[2-(4-tert-butylphenyl)ethyl]-5-(4-ethoxyphenyl)-1,3,4-oxadiazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42842-[2-(4-tert-butylphenyl)ethyl]-5-(4-methylphenyl)-1,3,4-oxadiazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42852-(4-ethoxyphenyl)-5-(2-phenylethyl)-1,3,4-oxadiazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42862-(4-methylphenyl)-5-(2-phenylethyl)-1,3,4-oxadiazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42874-{5-[2-(4-tert-butylphenyl)ethyl]-1,3,4-oxadiazol-2-yl}phenol
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42882-[(4-tert-butylphenyl)methyl]-5-(4-ethoxyphenyl)-1,3,4-oxadiazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42892-[(4-tert-butylphenyl)methyl]-5-(4-methylphenyl)-1,3,4-oxadiazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42904-(4-methylphenyl)-1-(2-phenylethyl)-1H-1,2,3-triazole
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4291(2E)-3-(4-tert-butylphenyl)-N-(5-methyl-1H-1,3-benzodiazol-2-yl)prop-2-enamide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4292(2E)-N-(1H-1,3-benzodiazol-2-yl)-3-(4-tert-butylphenyl)prop-2-enamide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_42933-(4-tert-butylphenyl)-N-(5-methyl-1H-1,3-benzodiazol-2-yl)propanamide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4294N-(1H-1,3-benzodiazol-2-yl)-3-(4-tert-butylphenyl)propanamide
NA
NA
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
NA
29499487
DrugRepV_4295Chloroquine
Antiparasitic products, Insectisides and Repellents
Malaria
Chikungunya virus
899
NA
CPE reduction assay
Decrease (50 %)
Approved
29499487
DrugRepV_61694-{1-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-3-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-5-yl}-2-methoxyphenol
NA
NA
Dengue virus
NA
Pathway
CPE reduction assay
Decrease (50 %)
NA
25791449
DrugRepV_61764-{[1,1-biphenyl]-4-yl}-2-[(2E)-2-(phenylmethylidene)hydrazin-1-yl]-1,3-thiazole
NA
NA
Dengue virus
NA
Pathway
CPE reduction assay
Decrease (50 %)
NA
25791449
DrugRepV_7976Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S2.1
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7977Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S2.2
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7978Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S2.3
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7979Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S3
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7980Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S4.1
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7981Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S4.3
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7982Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S5
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7983Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S7
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7984Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S8
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995
DrugRepV_7985Suramin
Antiparasitic products, Insectisides and Repellents
Sleeping sickness | Onchocerciasis
Chikungunya virus
S9
NA
CPE reduction assay
Decrease (50 %)
Investigational
32191995